Skip to content

2026 Fall Seminar Sessions

Back to Event
Register

Opening Remarks

8:00-8:15 AM

Location
Room: 1A001
Summary
Join us as we kick off the 2026 OSHP Fall Seminar with brief opening remarks, event highlights, and a welcome to attendees, speakers, exhibitors, and guests.

Measles Update - 2026

8:15-9:15 AM

Location
Room: 1A001
Speakers
  • Lorne Walker - MD, PhD OHSU, Associate Professor of Pediatrics, division of Pediatric Infectious Diseases - OSHU
Summary
Official elimination of endemic measles in the US was declared in the year 2000, making measles a disease of the past. Unfortunately, measles has returned to this country and is again causing illness and deaths. We will discuss the current status of measles in the US, the forces driving the return of measles, and how professionals and parents can find accurate, science-based advice.

BREAK and Networking with EXHIBITS

9:15-9:35 AM

Location
Atrium
Summary
Take a break, connect with our exhibitors, and learn more about the products, services, and resources they provide. Please take a moment to visit the booths and thank our exhibitors for their support of OSHP and the Fall Seminar.

Acute Ischemic Stroke: 2026 Guideline Updates

9:35-10:05 AM

Location
Room: 1A001
Speakers
  • Brendon Blaustein PharmD, BCPS, BCCCP
    Brendon Blaustein, PharmD, BCPS, BCCCP is a neurology clinical pharmacist practicing at OHSU. He received his PharmD from OSU/OHSU College of Pharmacy. Brendon has a passion for education and patient care. He enjoys precepting pharmacy students and residents, lecturing for the OSU College of Pharmacy, and serving on the Stroke Advisory Committee. Outside of work, he enjoys hiking, playing pickleball, and exploring Portland's diverse culinary scene.
Summary
The 2026 America Heart Association/American Stroke Association (AHA/ASA) Stroke Guidelines introduced clinically meaningful updates to the early management of acute ischemic stroke (AIS), replacing the 2018 guidelines and the 2019 update. Explore what’s new in the guidelines, examine the supporting evidence, and translate recommendations into clinical practice.

When Creatinine Doesn’t Cut It: Cystatin C in Drug Dosing

10:05-10:35 AM

Location
Room: 1A001
Speakers
  • Tianna Leitch - Clinical Pharmacist - Oregon Health & Science University
    Tianna Leitch, PharmD, is a clinical pharmacist at Oregon Health & Science University in Portland, Oregon, where she practices in emergency medicine and critical care. Her clinical interests include optimizing medication therapy in critically ill patients, improving medication safety, and management of mechanical circulatory support and shock states.
Summary
Cystatin C offers an additional approach to estimating kidney function when creatinine-based estimates are uncertain or potentially misleading. This presentation will provide pharmacists with a practical framework for understanding how, when, and why to incorporate Cystatin C into drug dosing decisions. It will discuss patient and clinical factors that can affect interpretation, and examine the implications of using different estimates of renal function for medication therapies.

BREAK and Networking with EXHIBITS

10:35-10:55 AM

Location
Atrium
Summary
Take a break, connect with our exhibitors, and learn more about the products, services, and resources they provide. Please take a moment to visit the booths and thank our exhibitors for their support of OSHP and the Fall Seminar.

Erythro-cation!

10:55-11:55 AM

Location
Room: 1A001
Speakers
  • Susie Jiing
  • Sheila McCollam - Oncology Clinical Supervisor - Oregon Health & Science University
    Shiela McCollam serves as one of the Oncology Clinical Pharmacy Supervisors and an Oncology Pharmacist for Oregon Health & Science University. She completed pharmacy school at Oregon State University (like her mother before her) and a residency with OHSU. Before Pharmacy school, she worked for 10 years a pharmacy technician in both the outpatient and inpatient setting. She is just a small-town girl, living in a lonely world of all ESAs all the time.
Summary
A presentation of OHSU's Erythropoietin Stimulating Agent Use Restriction Policy and Pharmacy Managed Clinical Practice Agreement created to intentionally operationalize pharmacy lead review of clinical appropriateness, patient safety and treatment optimization, and insurance billing requirements.

Mental Health and Wellbeing for Healthcare Professionals: The Neurobiology of Stress, and Complementary and Alternative Modalities to Build Resilience

12:30-1:30 PM

Location
Room: 1A001
Speakers
  • Gary Runyon - PharmD, RYT-500, Executive Directors - Oregon Board of Pharmacy
    A University of Tennessee College of Pharmacy graduate, Gary Runyon brings over 20 years of diverse experience to Oregon. He joined the Board of Pharmacy as a Compliance Officer in November 2023, advanced to Pharmacist Consultant, and became Executive Director in April 2024. His key accomplishments include overhauling the Board's approach to outreach and education, creating protocols for pharmacist-based MOUD prescribing, and championing licensee health and wellbeing by partnering with the Oregon Wellness Plan.
Summary
Healthcare professionals face a growing crisis of burnout driven by an expanding scope of practice, increasing demands, and decreasing resources. This session explores how this relentless stress physically impacts the brain, trapping us in a cycle of survival mode. Attendees will examine the hard science and practical application of complementary therapies like yoga, breathwork, clinical hypnosis, and Transcendental Meditation. By integrating these practices, clinicians can actively reset their nervous systems and build sustainable resilience.

Panel Discussion with Industry Partners

12:30-1:30 PM

Location
Room: 3A003A

Student Presentation TBD

12:30-1:30 PM

Location
Room: 3A003B

Afternoon Snack Break

1:35-1:55 PM

Location
Atrium
Summary
Enjoy a quick afternoon snack break, recharge, and take a few minutes to connect with colleagues before heading into the final sessions of the day.

The Case for Consensus: New Guidance and Evidence for the Management of MSSA Bacteremia

2:00-3:00 PM

Location
Room: 1A001
Speakers
  • Mara Gosch - PGY2 Critical Care Resident - OHSU
    Mara was born and raised in Minneapolis, MN and earned both her Bachelor of Science in Pharmacology & Toxicology and her Doctor of Pharmacy degree from the University of Wisconsin. She completed her PGY1 training at Oregon Health & Science University (OHSU), where she further developed her clinical interests in critical care and emergency medicine. She is currently the PGY2 critical care pharmacy resident at OHSU.
  • Anna Sandstrom - PGY2 Infectious Diseases Resident - OHSU
    Anna is from Vancouver, WA and earned both her Bachelor of Science in BioHealth Sciences and her Doctor of Pharmacy degrees from Oregon State University. She completed her PGY1 training at Providence Sacred Heart Medical Center, where she developed a passion for antimicrobial stewardship. She is currently the PGY2 Infectious Diseases pharmacy resident at Oregon Health & Science University.
Summary
This presentation will redefine risk stratification in the initial work-up and management of Staphylococcus aureus bacteremia (SAB). It will then evaluate new prospective evidence that compares cefazolin and antistaphylococcal penicillins for the treatment of methicillin-susceptible (MSSA) bacteremia, as well as penicillin and antistaphylococcal penicillins for the treatment of penicillin-susceptible (PSSA) bacteremia. The presentation will conclude with summarizing effective IV dosing and selecting evidence-based oral step-down antibiotic therapy for a patient with PSSA or MSSA bacteremia.

Student Presentation TBD

2:00-3:00 PM

Location
Room: 3A003B

Updates in Dyslipidemia Management: New Drugs, New Trials, New Guidelines, Oh My!

3:00-4:00 PM

Location
Room: 1A001
Speakers
  • Bruce Warden - Clinical Pharmacist - Oregon Health & Science University
    Dr. Warden is a Cardiovascular Pharmacy Specialist at the General Cardiology Clinic, Knight Cardiovascular Institute, OHSU in Portland, OR. He received his PharmD from Oregon State University / OHSU and completed a PGY1 residency at OHSU. Dr. Warden’s clinical practice area is cardiology, spanning inpatient acute care wards, cardiovascular intensive care unit and ambulatory settings including preventive cardiology, and general cardiology. Dr. Warden’s clinical and research interests include ASCVD risk reduction through cardiometabolic optimization, focusing on lipid and weight management.
Summary
In this presentation, attendees will 1. Identify patients at high risk for ASCVD and with clinical ASCVD requiring lipid screening and ASCVD risk stratification. 2. Summarize the impact of LDL-C on ASCVD development and the importance of achieving LDL-C goals to reduce the risk of ASCVD events. 3. Apply current guideline-based treatment recommendations for patients at high risk for ASCVD and with clinical ASCVD.

Happy Hour/Poster Display

4:00 PM

Location
Atrium
Summary
Wrap up the Fall Seminar with a relaxed happy hour featuring poster presentations, networking, and time to connect with colleagues and presenters.
Powered By GrowthZone
Scroll To Top